Literature DB >> 18356209

Observational evidence for determining drug safety.

Nick Freemantle, Alar Irs.   

Abstract

Mesh：

Year:  2008        PMID： 18356209      PMCID： PMC2270986          DOI： 10.1136/bmj.39491.493252.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The risk associated with aprotinin in cardiac surgery.

Authors:  Dennis T Mangano; Iulia C Tudor; Cynthia Dietzel
Journal:  N Engl J Med       Date:  2006-01-26       Impact factor: 91.245

2.  The FDA and drug safety: a proposal for sweeping changes.

Authors:  Curt D Furberg; Arthur A Levin; Peter A Gross; Robyn S Shapiro; Brian L Strom
Journal:  Arch Intern Med       Date:  2006-10-09

3.  Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.

Authors:  Dennis T Mangano; Yinghui Miao; Alain Vuylsteke; Iulia C Tudor; Rajiv Juneja; Daniela Filipescu; Andreas Hoeft; Manuel L Fontes; Zak Hillel; Elisabeth Ott; Tatiana Titov; Cynthia Dietzel; Jack Levin
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

Review 4.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.

Authors:  D A Henry; P A Carless; A J Moxey; D O'Connell; B J Stokes; B McClelland; A Laupacis; D Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  4 in total
  2 in total

1.  Controlled trials and risk of harm.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Observational evidence for determining drug safety: Too high a pedestal.

Authors:  Jeffrey K Aronson
Journal:  BMJ       Date:  2008-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.